Profile
Martin Latterich is the founder of The Nicholas Conor Institute Corp.
He is currently the Chief Scientific Officer at ProterixBio, Inc. He was previously the Senior Vice President-Technical Operations at Histogen, Inc. and a Professor at the Proteogenomics Research Institute for Systems Medicine.
Before that, he held positions such as Protemics Director at Illumina, Inc., Senior Director-Research & Development at Biomatrica, Inc., Assistant Professor at The Salk Institute for Biological Studies, and Principal Scientist at Diversa Corp.
He was also an Associate Professor at McGill University and the University of Montréal.
Dr. Latterich received his undergraduate and doctorate degrees from the University of Durham.
Martin Latterich active positions
| Companies | Position | Start |
|---|---|---|
ProterixBio, Inc.
ProterixBio, Inc. Medical SpecialtiesHealth Technology Supplies novel protein measurement technology | Chief Tech/Sci/R&D Officer | - |
Former positions of Martin Latterich
| Companies | Position | End |
|---|---|---|
Histogen, Inc. /Old/
Histogen, Inc. /Old/ Medical/Nursing ServicesHealth Services Researches, develops, manufactures and sells medicines | Chief Tech/Sci/R&D Officer | 30/04/2020 |
The Salk Institute for Biological Studies
The Salk Institute for Biological Studies Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
| HISTOGEN INC. | Chief Tech/Sci/R&D Officer | - |
The Nicholas Conor Institute Corp.
The Nicholas Conor Institute Corp. Miscellaneous Commercial ServicesCommercial Services Engaged in researching and developing cancer treatments for adolescents | Chief Executive Officer | - |
Proteogenomics Research Institute for Systems Medicine
Proteogenomics Research Institute for Systems Medicine BiotechnologyHealth Technology Provides research services | Corporate Officer/Principal | - |
Training of Martin Latterich
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
The Salk Institute for Biological Studies
The Salk Institute for Biological Studies Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Diversa Corp.
Diversa Corp. Miscellaneous Commercial ServicesCommercial Services Researches and develops genomic tools and biological technology for the agricultural industry | Commercial Services |
Illumina, Inc.
Illumina, Inc. Medical SpecialtiesHealth Technology Operates as a biotechnology company that develops laboratory instruments | Health Technology |
ProterixBio, Inc.
ProterixBio, Inc. Medical SpecialtiesHealth Technology Supplies novel protein measurement technology | Health Technology |
Biomatrica, Inc.
Biomatrica, Inc. BiotechnologyHealth Technology Provides innovative products for stabilizing biological samples and assays at ambient temperatures | Health Technology |
McGill University
McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Montréal
University of Montréal Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Durham
University of Durham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Histogen, Inc. /Old/
Histogen, Inc. /Old/ Medical/Nursing ServicesHealth Services Researches, develops, manufactures and sells medicines | Health Services |
The Nicholas Conor Institute Corp.
The Nicholas Conor Institute Corp. Miscellaneous Commercial ServicesCommercial Services Engaged in researching and developing cancer treatments for adolescents | Commercial Services |
Proteogenomics Research Institute for Systems Medicine
Proteogenomics Research Institute for Systems Medicine BiotechnologyHealth Technology Provides research services | Health Technology |
Histogen, Inc.
Histogen, Inc. BiotechnologyHealth Technology Operates as a clinical-stage therapeutics company that develops potential clinical and preclinical drugs | Health Technology |
- Stock Market
- Insiders
- Martin Latterich
















